Science News
from research organizations

Prescription Weight-Loss Drug Orlistat Approved For Over-the-Counter Sales

Date:
February 8, 2007
Source:
U.S. Food and Drug Administration
Summary:
The Food and Drug Administration (FDA) has approved orlistat capsules as an over-the-counter (OTC) weight loss aid for overweight adults. Orlistat helps produce weight loss by decreasing the intestinal absorption of fat.
Share:
FULL STORY

"We know that being overweight has many adverse consequences, including an increase in the risk of heart disease and type 2 diabetes," said Dr. Douglas Throckmorton, Deputy Director for FDA's Center for Drug Evaluation and Research.  "OTC orlistat, along with diet and exercise, may aid overweight adults who seek to lose excess weight to improve their health."

name Alli and is indicated for use in adults ages 18 years and older along with a reduced-calorie, low-fat diet, and exercise program. 

"We know that being overweight has many adverse consequences, including an increase in the risk of heart disease and type 2 diabetes," said Dr. Douglas Throckmorton, Deputy Director for FDA's Center for Drug Evaluation and Research.  "OTC orlistat, along with diet and exercise, may aid overweight adults who seek to lose excess weight to improve their health."

OTC orlistat is not for people who have problems absorbing food or for those who are not overweight. "Overweight" is defined by the National Institutes of Health as having a body mass index (BMI) of 27 kg/m2 or more.  Orlistat helps produce weight loss by decreasing the intestinal absorption of fat.  The 60 mg capsule can be taken up to three times a day with each fat-containing meal.  Because of the possible loss of certain nutrients, it is recommended that people using orlistat should also take a multivitamin at bedtime. 

The most common side effect of the product is a change in bowel habits, which may include loose stools.  Eating a low fat diet will reduce the likelihood of this side effect.  Also, people who have had an organ transplant should not take OTC orlistat because of possible drug interactions.  In addition, anyone taking blood thinning medicines or being treated for diabetes or thyroid disease should consult a physician before using orlistat. 

FDA approved OTC orlistat based on the review of the sponsor's safety data and after submitting the product for the consideration by an FDA advisory committee in January 2006. The committee voted in favor of OTC approval.


Story Source:

Materials provided by U.S. Food and Drug Administration. Note: Content may be edited for style and length.


Cite This Page:

U.S. Food and Drug Administration. "Prescription Weight-Loss Drug Orlistat Approved For Over-the-Counter Sales." ScienceDaily. ScienceDaily, 8 February 2007. <www.sciencedaily.com/releases/2007/02/070207214308.htm>.
U.S. Food and Drug Administration. (2007, February 8). Prescription Weight-Loss Drug Orlistat Approved For Over-the-Counter Sales. ScienceDaily. Retrieved May 23, 2017 from www.sciencedaily.com/releases/2007/02/070207214308.htm
U.S. Food and Drug Administration. "Prescription Weight-Loss Drug Orlistat Approved For Over-the-Counter Sales." ScienceDaily. www.sciencedaily.com/releases/2007/02/070207214308.htm (accessed May 23, 2017).

RELATED STORIES